Page 4 - Eric Moissenot News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Results
The PCAS Group has generated consolidated net sales of €194.1 million in fiscal year 2020, a decrease of 3.4% (-2.7% at constant exchange rates) compared to fiscal year 2019.
The EBITDA amounted to €10.7 million, compared to €16.3 million in 2019 (i.e. a margin of 5.5% versus 8.1% in 2019) and was primarily impacted negatively by the delay in commissioning the new production unit at the Villeneuve-la-Garenne site, the significant drop in demand for Lubricants linked to the coronavirus crisis as well as, to a lesser extent, the resources implemented to improve the industrial performance of several sites in the Pharmaceutical Synthesis activity. Consequently, the current operating income decreased to €-10.8 million, compared to €-3.5 million in 2019. ....

Emmanuel Huynh Louis Victor Delouvrier , Pierre Luzeau Eric Moissenot , Euronext Paris , Pharmaceutical Synthesis , Net Current Account , Annual General Meeting , Eric Moissenot , Louis Victor Delouvrier , மருந்து தொகுப்பு , நிகர தற்போதைய எண்ணுதல் , ஆண்டு ஜநரல் சந்தித்தல் ,